David J. Friedman

13.8k total citations · 3 hit papers
102 papers, 8.2k citations indexed

About

David J. Friedman is a scholar working on Nephrology, Molecular Biology and Genetics. According to data from OpenAlex, David J. Friedman has authored 102 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Nephrology, 31 papers in Molecular Biology and 25 papers in Genetics. Recurrent topics in David J. Friedman's work include Renal Diseases and Glomerulopathies (39 papers), Chronic Lymphocytic Leukemia Research (23 papers) and Chronic Kidney Disease and Diabetes (20 papers). David J. Friedman is often cited by papers focused on Renal Diseases and Glomerulopathies (39 papers), Chronic Lymphocytic Leukemia Research (23 papers) and Chronic Kidney Disease and Diabetes (20 papers). David J. Friedman collaborates with scholars based in United States, Israel and Spain. David J. Friedman's co-authors include Martin R. Pollak, Simon C. Robson, Giulio Genovese, Karen M. Dwyer, Terry B. Strom, Wenda Gao, Silvia Deaglio, Vijay K. Kuchroo, Joel Linden and Anny Usheva and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

David J. Friedman

97 papers receiving 8.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

2007 1.8k citations David J. Friedman, Simon C. Robson et al. profile →
Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans

2010 1.3k citations Giulio Genovese, David J. Friedman et al. Science profile →
Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants

2023 98 citations David J. Friedman, Martin R. Pollak et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
David J. Friedman	3.1k	2.1k	2.0k	1.2k	1.1k	102	8.2k
Jane E. Salmon	1.9k 0.6×	6.8k 3.2×	1.7k 0.9×	530 0.5×	153 0.1×	211	14.6k
Fokko J. van der Woude	2.7k 0.8×	2.4k 1.1×	2.0k 1.0×	1.5k 1.3×	100 0.1×	261	13.5k
William G. Couser	8.3k 2.6×	3.6k 1.7×	3.7k 1.8×	1.1k 1.0×	126 0.1×	217	15.7k
Patrick Niaudet	6.5k 2.1×	3.1k 1.5×	4.6k 2.3×	1.3k 1.1×	423 0.4×	295	13.4k
Hong Zhang	2.3k 0.7×	1.2k 0.6×	1.1k 0.6×	225 0.2×	70 0.1×	213	6.0k
Tomoko Takano	2.2k 0.7×	1.4k 0.7×	2.4k 1.2×	313 0.3×	56 0.0×	145	6.0k
P A Bacon	1.1k 0.3×	2.7k 1.3×	1.5k 0.7×	1.5k 1.3×	42 0.0×	194	11.4k
John R. Sedor	2.1k 0.7×	656 0.3×	2.2k 1.1×	498 0.4×	58 0.1×	150	6.2k
J. V. Dacie	892 0.3×	2.0k 0.9×	681 0.3×	1.9k 1.6×	219 0.2×	114	6.9k
Theodore M. Danoff	1.4k 0.4×	956 0.4×	2.7k 1.4×	458 0.4×	32 0.0×	47	6.7k

Countries citing papers authored by David J. Friedman

Since Specialization

Citations

This map shows the geographic impact of David J. Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Friedman more than expected).

Fields of papers citing papers by David J. Friedman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Friedman. The network helps show where David J. Friedman may publish in the future.

Co-authorship network of co-authors of David J. Friedman

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Friedman. A scholar is included among the top collaborators of David J. Friedman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Friedman. David J. Friedman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Friedman, David J., et al.. (2025). Association between Apolipoprotein L1 genetic variants and risk of preeclampsia and preterm birth among U.S. Black women. European Journal of Obstetrics & Gynecology and Reproductive Biology X. 25. 100365–100365. 1 indexed citations

Friedman, David J., et al.. (2025). Q-switch Tm:YAP laser for dermatology applications. 6–6.

Pollak, Martin R. & David J. Friedman. (2025). APOL1-associated kidney disease: modulators of the genotype-phenotype relationship. Current Opinion in Nephrology & Hypertension. 34(3). 191–198. 2 indexed citations

Friedman, David J., et al.. (2024). Evaluation of a Novel Ablative 1940 nm Pulsed Laser for Skin Rejuvenation. Lasers in Surgery and Medicine. 56(6). 592–596. 3 indexed citations

Simeone, Christopher A., Michelle T. McNulty, Yask Gupta, et al.. (2024). The APOL1 p.N264K variant is co-inherited with the G2 kidney disease risk variant through a proximity recombination event. G3 Genes Genomes Genetics. 15(2). 2 indexed citations

López-Pilarte, Damaris, et al.. (2023). Ethical considerations for genetic research in low-income countries: perceptions of informed consent, data sharing, and expectations in Nicaragua. European Journal of Human Genetics. 32(10). 1278–1284. 3 indexed citations

Raines, Nathan H., Dominick Leone, Cristina O’Callaghan‐Gordo, et al.. (2023). Metabolic Features of Increased Gut Permeability, Inflammation, and Altered Energy Metabolism Distinguish Agricultural Workers at Risk for Mesoamerican Nephropathy. Metabolites. 13(3). 325–325. 7 indexed citations

Dally, Miranda, Juan José Amador, Jaime Butler-Dawson, et al.. (2023). Point-of-Care Testing in Chronic Kidney Disease of Non-Traditional Origin: Considerations for Clinical, Epidemiological, and Health Surveillance Research and Practice. Annals of Global Health. 89(1). 2 indexed citations

Hall, Samantha, Nathan H. Raines, Oriana Ramírez‐Rubio, et al.. (2023). Urinary Metabolomic Profile of Youth at Risk of Chronic Kidney Disease in Nicaragua. Kidney360. 4(7). 899–908. 3 indexed citations

10.

Keogh, Sinead A., Emmanuel Jarquín, Damaris López-Pilarte, et al.. (2023). Heat stress and heat strain among outdoor workers in El Salvador and Nicaragua. Journal of Exposure Science & Environmental Epidemiology. 33(4). 622–630. 13 indexed citations

11.

Pollak, Martin R. & David J. Friedman. (2023). APOL1 and APOL1-Associated Kidney Disease: A Common Disease, an Unusual Disease Gene – Proceedings of the Henry Shavelle Professorship. SHILAP Revista de lepidopterología. 75–87. 14 indexed citations

12.

Scammell, Madeleine K., Rebecca L. Laws, Robert L. Rubin, et al.. (2020). Urinary Metals Concentrations and Biomarkers of Autoimmunity among Navajo and Nicaraguan Men. International Journal of Environmental Research and Public Health. 17(15). 5263–5263. 17 indexed citations

13.

Wang, Minxian, Justin Chun, Giulio Genovese, et al.. (2019). Contributions of Rare Gene Variants to Familial and Sporadic FSGS. Journal of the American Society of Nephrology. 30(9). 1625–1640. 35 indexed citations

14.

Shah, Shrijal S., et al.. (2019). Apolipoprotein L1 (APOL1) risk variant toxicity depends on the haplotype background. Kidney International. 96(6). 1303–1307. 40 indexed citations

15.

Ito, Kaoru, Alexander G. Bick, Jason Flannick, et al.. (2013). Increased Burden of Cardiovascular Disease in Carriers of APOL1 Genetic Variants. Circulation Research. 114(5). 845–850. 110 indexed citations

16.

Friedman, David J. & Martin R. Pollak. (2011). Genetics of kidney failure and the evolving story of APOL1. Journal of Clinical Investigation. 121(9). 3367–3374. 94 indexed citations

17.

Genovese, Giulio, David J. Friedman, Michael D. Ross, et al.. (2010). Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans. Science. 329(5993). 841–845. 1329 indexed citations breakdown →

18.

McDonald, W. Hayes & David J. Friedman. (2010). Leveraging Technologies: DIGE and MudPIT.. Journal of Biomolecular Techniques JBT. 21. 746881–746881. 1 indexed citations

19.

Friedman, David J., Beat Künzli, Yousif I. A-Rahim, et al.. (2009). CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proceedings of the National Academy of Sciences. 106(39). 16788–16793. 230 indexed citations

20.

Zhang, Yongqing, H Matthies, Joel Mancuso, et al.. (2004). The Drosophila fragile X-related gene regulates axoneme differentiation during spermatogenesis. Developmental Biology. 270(2). 290–307. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact